Sanofi (SNY) Competitors

$48.67
-0.15 (-0.31%)
(As of 05/17/2024 ET)

SNY vs. VRTX, REGN, GSK, BMY, PFE, ZTS, ABT, TAK, NVS, and AZN

Should you be buying Sanofi stock or one of its competitors? The main competitors of Sanofi include Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), GSK (GSK), Bristol-Myers Squibb (BMY), Pfizer (PFE), Zoetis (ZTS), Abbott Laboratories (ABT), Takeda Pharmaceutical (TAK), Novartis (NVS), and AstraZeneca (AZN). These companies are all part of the "pharmaceutical preparations" industry.

Sanofi vs.

Sanofi (NASDAQ:SNY) and Vertex Pharmaceuticals (NASDAQ:VRTX) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations, community ranking and profitability.

Vertex Pharmaceuticals has a net margin of 39.46% compared to Sanofi's net margin of 10.52%. Vertex Pharmaceuticals' return on equity of 23.08% beat Sanofi's return on equity.

Company Net Margins Return on Equity Return on Assets
Sanofi10.52% 19.69% 11.52%
Vertex Pharmaceuticals 39.46%23.08%17.71%

10.0% of Sanofi shares are held by institutional investors. Comparatively, 91.0% of Vertex Pharmaceuticals shares are held by institutional investors. 1.0% of Sanofi shares are held by company insiders. Comparatively, 0.2% of Vertex Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sanofi has higher revenue and earnings than Vertex Pharmaceuticals. Sanofi is trading at a lower price-to-earnings ratio than Vertex Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sanofi$46.61B2.64$5.84B$1.9924.46
Vertex Pharmaceuticals$9.87B11.64$3.62B$15.4128.89

In the previous week, Sanofi had 1 more articles in the media than Vertex Pharmaceuticals. MarketBeat recorded 16 mentions for Sanofi and 15 mentions for Vertex Pharmaceuticals. Vertex Pharmaceuticals' average media sentiment score of 1.00 beat Sanofi's score of 0.66 indicating that Vertex Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sanofi
7 Very Positive mention(s)
0 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Vertex Pharmaceuticals
11 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Vertex Pharmaceuticals received 1518 more outperform votes than Sanofi when rated by MarketBeat users. Likewise, 75.62% of users gave Vertex Pharmaceuticals an outperform vote while only 53.23% of users gave Sanofi an outperform vote.

CompanyUnderperformOutperform
SanofiOutperform Votes
33
53.23%
Underperform Votes
29
46.77%
Vertex PharmaceuticalsOutperform Votes
1551
75.62%
Underperform Votes
500
24.38%

Sanofi currently has a consensus target price of $55.00, indicating a potential upside of 13.01%. Vertex Pharmaceuticals has a consensus target price of $432.18, indicating a potential downside of 2.93%. Given Sanofi's higher probable upside, research analysts clearly believe Sanofi is more favorable than Vertex Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sanofi
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Vertex Pharmaceuticals
3 Sell rating(s)
7 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.48

Sanofi has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, Vertex Pharmaceuticals has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500.

Summary

Vertex Pharmaceuticals beats Sanofi on 12 of the 18 factors compared between the two stocks.

Get Sanofi News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNY vs. The Competition

MetricSanofiPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$123.12B$6.71B$5.08B$7.95B
Dividend Yield3.02%2.72%36.93%3.91%
P/E Ratio24.4615.17149.4316.85
Price / Sales2.64256.242,348.8776.74
Price / Cash7.6635.6336.1232.08
Price / Book1.536.105.714.68
Net Income$5.84B$139.32M$104.82M$216.90M
7 Day Performance-1.24%1.44%1.92%2.94%
1 Month Performance5.55%2.98%4.23%6.23%
1 Year Performance-9.35%-1.55%6.42%9.80%

Sanofi Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VRTX
Vertex Pharmaceuticals
4.1464 of 5 stars
$428.59
-0.3%
$432.18
+0.8%
+30.5%$110.60B$9.87B27.815,400
REGN
Regeneron Pharmaceuticals
4.0474 of 5 stars
$984.64
+0.8%
$981.71
-0.3%
+31.0%$108.50B$13.12B29.0913,450Analyst Forecast
Insider Selling
GSK
GSK
1.9425 of 5 stars
$45.66
+1.1%
N/A+24.5%$94.63B$30.74B16.5470,200News Coverage
BMY
Bristol-Myers Squibb
4.9943 of 5 stars
$44.73
-0.7%
$60.00
+34.1%
-33.8%$90.67B$45.01B-14.4334,100
PFE
Pfizer
4.9975 of 5 stars
$28.35
-0.3%
$35.86
+26.5%
-22.1%$160.65B$58.50B-472.4288,000
ZTS
Zoetis
4.6667 of 5 stars
$168.87
+0.6%
$211.75
+25.4%
-2.7%$77.06B$8.54B32.5414,100
ABT
Abbott Laboratories
4.9649 of 5 stars
$104.00
-0.7%
$121.50
+16.8%
-4.3%$180.92B$40.11B32.40114,000Insider Selling
Short Interest ↑
Positive News
TAK
Takeda Pharmaceutical
0.983 of 5 stars
$13.45
+2.6%
$14.00
+4.1%
-18.8%$42.57B$28.20B24.4549,095Gap Up
NVS
Novartis
2.4535 of 5 stars
$103.31
+1.0%
$115.00
+11.3%
+1.3%$211.17B$47.73B13.9476,057
AZN
AstraZeneca
2.5857 of 5 stars
$77.04
-0.5%
$81.00
+5.1%
+2.9%$238.86B$45.81B37.7689,900Analyst Revision

Related Companies and Tools

This page (NASDAQ:SNY) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners